resveratrol has been researched along with Cancer of the Uterus in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Changou, CA; Chen, YR; Chin, YT; Chou, SY; Davis, PJ; Ho, Y; Lin, HY; Lin, SJ; Liu, HL; Sh Yang, YC; Shih, YJ; Tang, HY; Whang-Peng, J | 1 |
| Alayev, A; Holz, MK; Li, C; Salamon, RS; Schwartz, NS; Sun, Y; Yu, JJ | 1 |
| Chang, YC; Kim, CH; Kim, DI; Lee, DK; Lee, TK; Lee, YC | 1 |
| Balulad, SS; Bennett, JA; Keller, RS; Rezk, YA | 1 |
| Asselin, E; LeBlanc, K; Lemoine, P; Parent, S; Sexton, E; Van Themsche, C | 1 |
5 other study(ies) available for resveratrol and Cancer of the Uterus
| Article | Year |
|---|---|
Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R.
Topics: Cell Proliferation; Female; Flow Cytometry; Humans; In Situ Nick-End Labeling; Integrin alphaVbeta3; Leiomyoma; Phosphorylation; Receptor Cross-Talk; Receptor, IGF Type 1; Resveratrol; Stilbenes; Uterine Neoplasms | 2018 |
Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphangioleiomyomatosis; Mechanistic Target of Rapamycin Complex 1; Mice, SCID; Multiprotein Complexes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Signal Transduction; Sirolimus; Stilbenes; TOR Serine-Threonine Kinases; Treatment Outcome; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Uterine Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Inhibitory effects of Scutellaria barbata D. Don on human uterine leiomyomal smooth muscle cell proliferation through cell cycle analysis.
Topics: Antineoplastic Agents; Berberine; Blotting, Western; Cell Cycle; Cell Proliferation; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Flavonoids; Flow Cytometry; Humans; Leiomyoma; Myocytes, Smooth Muscle; Myometrium; Plant Extracts; Plant Stems; Resveratrol; Scutellaria; Stilbenes; Tumor Cells, Cultured; Uterine Neoplasms | 2004 |
Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bradycardia; Cardiotonic Agents; Cell Division; Cell Survival; Cells, Cultured; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Female; Humans; Long QT Syndrome; Mice; Myocytes, Cardiac; Ovarian Neoplasms; Rats; Resveratrol; Stilbenes; Uterine Neoplasms | 2006 |
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells.
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Endometrial Neoplasms; Female; HeLa Cells; Humans; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Uterine Neoplasms | 2006 |